To further explore the physiological role of NF-κB activation on the development of hypertension in offspring of prenatal inflammatory stimulation, we used the inhibitor of IκBα degradation, PDTC, in vivo to block NF-κB activation simultaneously with LPS stimulation or postnatally in adulthood. This evidence concerns the gene NFKB1 and hypertensive disorder.